Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey
NCT ID: NCT04317690
Last Updated: 2022-05-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
539 participants
OBSERVATIONAL
2020-03-17
2020-06-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions
NCT04601272
A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer
NCT03721926
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
NCT03766009
Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)
NCT02263014
Study of Decision Making in Patients Participating in Phase I Clinical Trials
NCT00054223
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sample is an online non-probability panel of adults living in the United States. In the survey, participants were screened to meet specific qualifications. After 1 week, a random selection of 50 respondents are invited to complete the retest instrument.
All analyses will be conducted separately for each group, and results may be pooled across cancer screening and medication contexts. First, study staff will examine the descriptives for the Shared Decision Making Process items. Study staff will also test several hypotheses to examine validity of the scores such as whether higher shared decision making process scores are associated with less decisional conflict and less regret. Staff will also examine retest reliability of the Shared Decision Making Process scale.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Cholesterol
People between the ages of 30-75 ,with no previous heart attack or stroke history, who have been diagnosed with high cholesterol, who are either taking medication for high cholesterol for 2 years or less; or have discussed managing high cholesterol in the past 2 years. These people will see items only pertaining to high cholesterol.
No interventions assigned to this group
High Blood Pressure
People between the ages of 30-75 ,with no previous heart attack or stroke history, who have been diagnosed with high blood pressure, who are either taking medication for high blood pressure for 2 years or less; or have discussed managing high blood pressure in the past 2 years. These people will see items only pertaining to high blood pressure.
No interventions assigned to this group
Colorectal Cancer Screening
People between the ages of 50-75 with no previous diagnosis of colon cancer, who have been screened for colon cancer (or discussed screening for colon cancer) in the past 2 years, or who had first colon cancer screening in past 2 years. These people will see items only pertaining to colon cancer screening.
No interventions assigned to this group
Breast Cancer Screening
Females between the ages of 40-50 with no previous diagnosis of breast cancer who have had mammogram (or discussed having a mammogram) in the past 2 years, or had first mammogram in past 2 years. These people will see items only pertaining to breast cancer screening.
No interventions assigned to this group
Prostate Cancer Screening
Men between the ages of 45-69 with no previous diagnosis of prostate cancer who have been screened for prostate cancer (or discussed screening for prostate cancer) in the past 2 years or had first prostate cancer screening in the past 2 years. These people will see items only pertaining to prostate cancer screening.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the ages of 30-75
* No previous heart attack or stroke
* Have been diagnosed with high blood pressure
* Taking medication for high blood pressure for 2 years or less; or have discussed managing high blood pressure in the past 2 years
High Cholesterol
* Between the ages of 30-75
* No previous heart attack or stroke
* Have been diagnosed with high cholesterol
* Taking medication for high cholesterol for 2 years or less; or have discussed managing high cholesterol in the past 2 years
Colorectal Cancer Screening
* Between the ages of 50-75
* No previous diagnosis of colon cancer
* Have been screened for colon cancer (or discussed screening for colon cancer) in the past 2 years
* Had first colon cancer screening in past 2 years
Breast Cancer Screening
* Female
* Between the ages of 40-55
* No previous diagnosis of breast cancer
* Have had mammogram (or discussed having a mammogram) in the past 2 years
* Had first mammogram in past 2 years
Prostate Cancer Screening
* Male
* Between the ages of 45-69
* No previous diagnosis of prostate cancer
* Have been screened for prostate cancer (or discussed screening for prostate cancer) in the past 2 years
* Had first prostate cancer screening in past 2 years
Exclusion Criteria
* None
High Cholesterol
* None
Colorectal Cancer Screening
* None
Breast Cancer Screening
* None
Prostate Cancer Screening
* None
30 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Massachusetts, Boston
OTHER
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karen Sepucha
Director of the Health Decision Sciences Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen Sepucha, PhD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019P001434-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.